Cullinan Therapeutics (CGEM) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
CGEM is expected to report earnings to rise 14.32% to -78 cents per share on March 06
Q4'24
Est.
$-0.79
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.13
Q4'23
Beat
by $0.42
The last earnings report on November 07 showed earnings per share of -68 cents, beating the estimate of -78 cents. With 58.09K shares outstanding, the current market capitalization sits at 669.04M.